To investigate the role of
opioids in regulating cardiovascular function, we administered
delta-opioid receptor agonists D-Ala-D-
Leu enkephalin (
DADLE) and D-Ala-
Met enkephalinamide (
DAME), and
mu-opioid receptor agonist, a
morphiceptin analogue (MA), intracisternally in 13 unanesthetized, chronically instrumented adult dogs in 2 doses (25 and 125 micrograms/kg). After an initial transient drop, the R-R interval increased (peak approximately 25-60 min) postadministration of
opioids. The time course and the magnitude of the change in R-R interval depended on the agonist: delta-agonists induced a more prolonged and marked change in R-R interval than mu-agonists at both doses. Mean arterial blood pressure (MAP) increased initially but dropped toward or even below base line 30 min after
opioids administration.
Atropine, given intravenously or intra-arterially at peak action of agonist in relatively low doses (0.02 mg/kg), induced an
AV block followed by a marked decrease in R-R interval. There was also an increase in MAP after
atropine.
Naloxone, given intracisternally, reversed both delta- and mu-
opioid effects but did not induce changes in the R-R interval without prior administration of
opioids. We conclude that in unanesthetized adult dogs 1) both mu- and
delta-receptor opioid agonists prolong the R-R interval, and this depends on the type of receptor stimulated; 2)
opioids induce slowing in heart rate, possibly by increasing parasympathetic activity to the heart; 3)
enkephalin and
morphiceptin analogues induce a biphasic response in MAP; and 4)
endorphins do not modulate cardiovascular function tonically; we speculate that they can alter the R-R interval and MAP in the presence of stimuli.